WDR45 antibody (AA 312-322) (Atto 488)
Quick Overview for WDR45 antibody (AA 312-322) (Atto 488) (ABIN5066247)
Target
See all WDR45 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 312-322
-
Specificity
- Ubiquitously expressed, with high expression in skeletal muscle and heart. Weakly expressed in liver and placenta. Expression is down-regulated in pancreatic and in kidney tumors.,Detects ~40 kDa.
-
Cross-Reactivity
- Human, Rat
-
Purification
- Peptide Affinity Purified
-
Immunogen
- Synthetic peptide from the C-terminal of Human WIPI4 (aa. 312-322)
-
Isotype
- IgG
-
-
-
-
Application Notes
-
- WB (1:1000)
- ICC/IF (1:100)
- optimal dilutions for assays should be determined by the user.
-
Comment
-
A 1:1000 dilution of ABIN5066247 was sufficient for detection of WIPI4 in 15 μg of Human HeLa Cell Lysates by ECL immunoblot analysis using goat anti-rabbit IgG:HRP as the secondary antibody.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- PBS, 50 % glycerol, 0.09 % sodium azide, Storage buffer may change when conjugated
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
Storage Comment
- Conjugated antibodies should be stored at 4°C
-
-
- WDR45 (WD Repeat Domain 45 (WDR45))
-
Alternative Name
- WDR45
-
Background
- WIPI-4 is a 360 amino acid protein containing three WD repeats. Existing as three alternatively spliced isoforms, WIPI-4 is ubiquitously expressed but found at highest levels in heart and skeletal muscle. WD repeat proteins are involved in a variety of cellular processes, including cell cycle progression, signal transduction, apoptosis, and gene regulation. Diseases associated with this gene include neurodegeneration with brain iron accululation 5 and 4.
-
Gene ID
- 11152
-
NCBI Accession
- NP_001025067
-
UniProt
- Q9Y484
Target
-